Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Sirolimus for Dry Eye Disease
NCT04115800Phase 1Completed
- Sponsor
- Instituto de Oftalmología Fundación Conde de Valenciana
- Start
- Oct 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in dry eye disease (DED) comparing Liposomal Sirolimus with Liposomal Placebo (2 arms). Primary endpoint: Ocular Surface Disease Index at 6 weeks. Started Oct 2019; status: completed.
02
Drugs
sirolimus
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04115800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04115800.